Comparison of CVF (Cyclophosphamide+Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide+Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer

PURPOSE: Our study aimed to evaluate the feasibility of adjuvant cyclophosphamide/vinorelbine/5-fluorourail (CVF) chemotherapy as an alternative to cyclophosphamide/methotrexate/5-fluorouracil (CMF) chemotherapy for treating early breast cancer. METHODS: One hundred and forty-nine patients were rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Gwak, Geumhee, Park, Kyeongmee, Shin, Eunah, Han, Sehwan, Kim, Ji-Young, Kim, Hongyong, Kim, Young Duk, Kim, Hong Ju, Kim, Ki Whan, Bae, Byung Noe, Yang, Keun Ho, Cho, Hyunjin, Park, Sung-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200519/
https://www.ncbi.nlm.nih.gov/pubmed/22031805
http://dx.doi.org/10.4048/jbc.2011.14.3.223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200519/
https://www.ncbi.nlm.nih.gov/pubmed/22031805
http://dx.doi.org/10.4048/jbc.2011.14.3.223

Ejemplares similares